Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Klin Med (Mosk) ; 87(11): 71-3, 2009.
Article in Russian | MEDLINE | ID: mdl-20143572

ABSTRACT

This paper reports the result of surgical treatment of a patient with hemodynamically significant post-infarction left ventricular aneurysm spreading over the apex, anterolateral wall of the left ventricle, and a major part of interventricular septum complicated by thromboendocarditis.


Subject(s)
Cardiac Surgical Procedures/methods , Endocarditis/etiology , Heart Aneurysm/surgery , Myocardial Infarction/complications , Thrombosis/etiology , Echocardiography, Transesophageal , Endocarditis/diagnosis , Endocarditis/surgery , Follow-Up Studies , Heart Aneurysm/complications , Heart Aneurysm/diagnosis , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Thrombosis/diagnosis , Thrombosis/surgery
3.
Klin Med (Mosk) ; 72(1): 41-4, 1994.
Article in Russian | MEDLINE | ID: mdl-8196323

ABSTRACT

In the study of 164 patients with atherogenic dyslipidemia the authors studied side effects of aiconol, concentrated cod liver oil. Its lipid component contains not less than 18% of omega-3 polyunsaturated fatty acids (PUFA). All the patients were divided into 4 groups: 51 subjects of group 1 received aiconol in the form of oil, 35 subjects of group 2 had protein dietetic caviar prepared from animal proteins with addition of 3% aiconol, 38 subjects of group 3 were given protein-oil emulsion containing 20% aiconol and 40 patients of group 4 took gelatin aiconol in capsules. Side effects of the above food ingredients enriched with omega-3 PUFA were found to be of metabolic nature. These manifested most evidently in patients on oil aiconol incorporating both maximal doses of omega-3 PUFA and the largest amounts of inert constituents acting as additional fat load on the liver and pancreas. Group 1 patients also suffered from aggravated chronic gastrointestinal, hepatic and pancreatic disorders. Because of reduced quantities of omega-3 PUFA in the diets of group 2, 3 and 4 patients, they displayed much less severe side effects.


Subject(s)
Cod Liver Oil/adverse effects , Dietary Proteins/administration & dosage , Feeding and Eating Disorders/chemically induced , Gastrointestinal Diseases/chemically induced , Hyperlipidemias/diet therapy , Adult , Aged , Cod Liver Oil/chemistry , Cod Liver Oil/pharmacokinetics , Cod Liver Oil/therapeutic use , Dosage Forms , Fatty Acids, Omega-3/analysis , Feeding and Eating Disorders/metabolism , Female , Gastrointestinal Diseases/metabolism , Humans , Hyperlipidemias/metabolism , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...